Spyre Therapeutics, Inc. (SYRE)
91.97
+1.72
(+1.91%)
USD |
NASDAQ |
Sep 21, 16:00
91.97
0.00 (0.00%)
After-Hours: 20:00
Spyre Therapeutics Total Return Price : 91.97 for Sept. 21, 2026
Total Return Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Price Data
| Date | Value |
|---|---|
| September 18, 2026 | 90.25 |
| September 17, 2026 | 92.68 |
| September 16, 2026 | 91.17 |
| September 15, 2026 | 90.95 |
| September 14, 2026 | 90.80 |
| September 11, 2026 | 90.60 |
| September 10, 2026 | 88.71 |
| September 09, 2026 | 86.93 |
| September 08, 2026 | 90.79 |
| September 04, 2026 | 88.98 |
| September 03, 2026 | 87.25 |
| September 02, 2026 | 87.05 |
| September 01, 2026 | 88.50 |
| August 31, 2026 | 89.33 |
| August 28, 2026 | 90.36 |
| August 27, 2026 | 93.62 |
| August 26, 2026 | 93.60 |
| August 25, 2026 | 107.36 |
| August 24, 2026 | 106.65 |
| August 21, 2026 | 106.49 |
| August 20, 2026 | 107.79 |
| August 19, 2026 | 108.92 |
| August 18, 2026 | 107.82 |
| August 17, 2026 | 104.60 |
| August 14, 2026 | 103.63 |
| Date | Value |
|---|---|
| August 13, 2026 | 101.85 |
| August 12, 2026 | 104.09 |
| August 11, 2026 | 102.74 |
| August 10, 2026 | 105.33 |
| August 07, 2026 | 104.91 |
| August 06, 2026 | 103.42 |
| August 05, 2026 | 104.35 |
| August 04, 2026 | 104.94 |
| August 03, 2026 | 94.93 |
| July 31, 2026 | 98.33 |
| July 30, 2026 | 101.50 |
| July 29, 2026 | 97.87 |
| July 28, 2026 | 99.96 |
| July 27, 2026 | 100.04 |
| July 24, 2026 | 102.13 |
| July 23, 2026 | 99.99 |
| July 22, 2026 | 99.17 |
| July 21, 2026 | 102.70 |
| July 20, 2026 | 97.33 |
| July 17, 2026 | 100.23 |
| July 16, 2026 | 94.12 |
| July 15, 2026 | 102.07 |
| July 14, 2026 | 98.95 |
| July 13, 2026 | 93.73 |
| July 10, 2026 | 97.74 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| AbbVie, Inc. | 264.50 |
| Incyte Corp. | 124.69 |
| SELLAS Life Sciences Group, Inc. | 11.37 |
| BridgeBio Pharma, Inc. | 66.54 |
| Relay Therapeutics, Inc. | 18.19 |